NDLI: TERT PROMOTER MUTATIONS CONTRIBUTE TO PROGNOSTIC SUBGROUPS OF LOWER GRADE ASTROCYTOMAS

Content Provider	PubMed Central
Author	Ng, Ho Keung Chan, Aden Yao, Yu Chan, Danny
Copyright Year	2014
Abstract	BACKGROUND: Recurrent mutations in the promoter region of TERT (telomerase reverse transcriptase) have been found in various cancers including diffuse gliomas. Mutations lead to TERT upregulation and are associated with aggressive clinical behaviour in glioblastomas. However, the prognostic impact of TERT promoter mutations in lower grade gliomas remains undetermined. METHODS: The aim of this study is to evaluate the status of TERT promoter and the respective clinical significance in a cohort of 181 lower grade gliomas comprising grades II and III astrocytomas, oligodendrogliomas and oligoastrocytomas. RESULTS: Mutually exclusive mutations in TERT promoter, C228T and C250T, were identified in 12/89 (14%) diffuse astrocytomas, 8/23 (35%) anaplastic astrocytomas, 13/18 (72%) oligodendrogliomas, 3/3 (100%) anaplastic oligodendrogliomas, 17/45 (38%) oligoastrocytomas and 2/3 (67%) anaplastic oligoastrocytomas. Mutations co-occurred with 1p/19q codeletion (p < 0.001), IDH mutation (p = 0.025) and are associated with oligodendroglial histology (p < 0.001). Kaplan-Meier's survival analysis showed that IDH mutation (p = 0.027) and 1p/19q codeletion (p = 0.001) were associated with longer progression-free survival. TERT promoter mutation (p = 0.017), IDH mutation (p = 0.004) and 1p/19q codeletion (p < 0.001) were associated with favorable overall survival. In the subset of 90 IDH mutated lower grade gliomas lacking 1p/19q codeletion, 16 TERT promoter mutated tumors exhibited longer overall survival (p = 0.017). Consistent with this observation, in the subset of 71 IDH mutated astrocytomas, 11 TERT promoter mutated tumors showed longer progression-free survival (p = 0.003) and overall survival (p = 0.005). In contrast, among the subset of 46 IDH wild type lower grade gliomas, TERT promoter mutation was associated with shorter progression-free survival (p = 0.001) and overall survival (p = 0.001). Similarly, in the subset of 37 IDH wild type lower grade gliomas with intact 1p19q, 8 TERT promoter mutated tumors exhibited unfavorable progression-free survival (p = 0.005) and overall survival (p = 0.008). IDH included IDH1 and IDH2. CONCLUSIONS: Our results indicate that when combined with IDH status, TERT promoter mutation contributes to prognostic subgroups of lower grade astrocytic tumors (1p/19q intact low grade gliomas) and this may further refine future molecular classification of lower grade gliomas. SECONDARY CATEGORY: Clinical Neuro-Oncology.
Related Links	http://dx.doi.org/10.1093/neuonc/nou209.12
Starting Page	45
File Format	PDF
ISSN	15228517
e-ISSN	15235866
Journal	Neuro-Oncology
Issue Number	Suppl 3
Volume Number	16
Language	English
Publisher	Oxford University Press
Publisher Date	2014-07-01
Access Restriction	Open
Rights Holder	Oxford University Press
Subject Keyword	Cancer Research Oncology Clinical Neurology Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Cancer Research Neurology (clinical) Oncology

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

P04.06TERT PROMOTER MUTATIONS CONTRIBUTE TO SUBSET PROGNOSTICATION OF LOWER GRADE GLIOMAS

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas

Erratum to: The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas

H3K27M and TERT promoter mutations are poor prognostic factors in surgical cases of adult thalamic high-grade glioma

High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas

Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas

TERT PROMOTER MUTATIONS CONTRIBUTE TO PROGNOSTIC SUBGROUPS OF LOWER GRADE ASTROCYTOMAS

Similar Documents

P04.06TERT PROMOTER MUTATIONS CONTRIBUTE TO SUBSET PROGNOSTICATION OF LOWER GRADE GLIOMAS

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas

Erratum to: The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas

H3K27M and TERT promoter mutations are poor prognostic factors in surgical cases of adult thalamic high-grade glioma

High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas

Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas.

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas

TERT PROMOTER MUTATIONS CONTRIBUTE TO PROGNOSTIC SUBGROUPS OF LOWER GRADE ASTROCYTOMAS